クオール HD（3034）のセグメントごとの売上高・利益等
セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
|---|---|---|---|---|---|---|
| 売上高 | 2013/03 | - | - | 719億 | - | - |
| 2014/03 | - | - | 913億 +27% | - | - | |
| 2015/03 | - | - | 1032億 +13.1% | - | - | |
| 2016/03 | - | - | 1153億 +11.7% | - | 96.5億 | |
| 2017/03 | - | - | 1206億 +4.6% | - | 109億 +13% | |
| 2018/03 | - | - | 1351億 +12% | - | 104億 -4.3% | |
| 2019/03 | - | - | 1341億 -0.7% | - | 107億 +2.2% | |
| 2020/03 | - | 122億 | 1532億 +14.2% | - | 122億 +14.7% | |
| 2021/03 | - | 131億 +7.2% | 1487億 -2.9% | - | - | |
| 2022/03 | - | 131億 -0.1% | 1531億 +2.9% | - | - | |
| 2023/03 | - | 147億 +12% | 1554億 +1.5% | - | - | |
| 2024/03 | 16.2億 | 150億 +2% | 1651億 +6.3% | - | 133億 | |
| 2025/03 | 787億 +999.99% | - | 1716億 +4% | - | 136億 +2% | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| 営業利益 | 2013/03 | - | - | 39.4億 | - | - |
| 2014/03 | - | - | 30.4億 -23% | - | - | |
| 2015/03 | - | - | 44.2億 +45.5% | - | - | |
| 2016/03 | - | - | 67.1億 +51.9% | - | 10億 | |
| 2017/03 | - | - | 61.6億 -8.2% | - | 15億 +49.8% | |
| 2018/03 | - | - | 86.5億 +40.4% | - | 13.4億 -10.5% | |
| 2019/03 | - | - | 63.5億 -26.6% | - | 13.7億 +1.9% | |
| 2020/03 | - | 13.4億 | 72.6億 +14.3% | - | 13.4億 -1.6% | |
| 2021/03 | - | 14.8億 +9.8% | 96.1億 +32.4% | - | - | |
| 2022/03 | - | 11.9億 -19.4% | 119億 +23.5% | - | - | |
| 2023/03 | - | 15.3億 +28.9% | 115億 -3.1% | - | - | |
| 2024/03 | -4.12億 | 11.4億 -25.9% | 107億 -6.7% | - | 15.5億 | |
| 2025/03 | 52.7億 | - | 100億 -6.5% | - | 17.1億 +10.1% | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| 営業利益率 | 2013/03 | - | - | 5.5% | - | - |
| 2014/03 | - | - | 3.3% -2.2% | - | - | |
| 2015/03 | - | - | 4.3% +1% | - | - | |
| 2016/03 | - | - | 5.8% +1.5% | - | 10.4% | |
| 2017/03 | - | - | 5.1% -0.7% | - | 13.7% +3.3% | |
| 2018/03 | - | - | 6.4% +1.3% | - | 12.9% -0.8% | |
| 2019/03 | - | - | 4.7% -1.7% | - | 12.8% -0.1% | |
| 2020/03 | - | 11% | 4.7% ±0% | - | 11% -1.8% | |
| 2021/03 | - | 11.3% +0.3% | 6.5% +1.8% | - | - | |
| 2022/03 | - | 9.1% -2.2% | 7.7% +1.2% | - | - | |
| 2023/03 | - | 10.5% +1.4% | 7.4% -0.3% | - | - | |
| 2024/03 | -25.4% | 7.6% -2.9% | 6.5% -0.9% | - | 11.6% | |
| 2025/03 | 6.7% | - | 5.8% -0.7% | - | 12.5% +0.9% | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| 設備投資額 | 2013/03 | - | - | - | - | - |
| 2014/03 | - | - | - | - | - | |
| 2015/03 | - | - | - | - | - | |
| 2016/03 | - | - | - | - | - | |
| 2017/03 | - | - | - | - | - | |
| 2018/03 | - | - | - | - | - | |
| 2019/03 | - | - | 59.7億 | - | - | |
| 2020/03 | - | - | 154億 +157.3% | - | - | |
| 2021/03 | - | - | 16.8億 -89% | - | - | |
| 2022/03 | - | - | 14.5億 -13.9% | - | - | |
| 2023/03 | - | - | 42億 +189.7% | - | - | |
| 2024/03 | - | - | 20.7億 -50.8% | - | - | |
| 2025/03 | - | - | 49億 +137% | - | - | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| 固定資産増加額 | 2013/03 | - | - | 41億 | - | - |
| 2014/03 | - | - | 88.3億 +115.6% | - | - | |
| 2015/03 | - | - | 62.2億 -29.6% | - | - | |
| 2016/03 | - | - | 35.3億 -43.3% | - | 62百万 | |
| 2017/03 | - | - | 129億 +265.7% | - | 21百万 -66.1% | |
| 2018/03 | - | - | 35.8億 -72.2% | - | 44百万 +109.5% | |
| 2019/03 | - | - | 59.7億 +66.6% | - | 246百万 +459.1% | |
| 2020/03 | - | 38百万 | 154億 +157.3% | - | 38百万 -84.6% | |
| 2021/03 | - | 407百万 +971.1% | 29.4億 -80.9% | - | - | |
| 2022/03 | - | 223百万 -45.2% | 31.2億 +6.3% | - | - | |
| 2023/03 | - | 205百万 -8.1% | 84.9億 +171.8% | - | - | |
| 2024/03 | 0.99億 | 939百万 +358% | 39.9億 -52.9% | - | 839百万 | |
| 2025/03 | 355億 +999.99% | - | 59.6億 +49.1% | - | 108百万 -87.1% | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| 従業員数 | 2013/03 | - | - | - | - | - |
| 2014/03 | - | - | - | - | - | |
| 2015/03 | - | - | - | - | - | |
| 2016/03 | - | - | - | - | - | |
| 2017/03 | - | - | - | - | - | |
| 2018/03 | - | - | - | - | - | |
| 2019/03 | - | - | 4,252 | - | 721 | |
| 2020/03 | - | - | 4,427 +4.1% | - | 831 +15.3% | |
| 2021/03 | - | 813 | 4,604 +4% | - | - | |
| 2022/03 | - | 817 +0.5% | 4,692 +1.9% | - | - | |
| 2023/03 | - | 803 -1.7% | 4,836 +3.1% | - | - | |
| 2024/03 | - | 819 +2% | 4,921 +1.8% | - | - | |
| 2025/03 | 330 | - | - | 5,027 | 794 | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| 平均臨時雇用人員 | 2013/03 | - | - | - | - | - |
| 2014/03 | - | - | - | - | - | |
| 2015/03 | - | - | - | - | - | |
| 2016/03 | - | - | - | - | - | |
| 2017/03 | - | - | - | - | - | |
| 2018/03 | - | - | - | - | - | |
| 2019/03 | - | - | 1,813 | - | 97 | |
| 2020/03 | - | - | 2,123 +17.1% | - | 176 +81.4% | |
| 2021/03 | - | 204 | 2,063 -2.8% | - | - | |
| 2022/03 | - | 219 +7.4% | 1,877 -9% | - | - | |
| 2023/03 | - | 281 +28.3% | 1,860 -0.9% | - | - | |
| 2024/03 | - | 319 +13.5% | 1,923 +3.4% | - | - | |
| 2025/03 | 239 | - | - | 1,967 | 300 | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| 資産 | 2013/03 | - | - | 346億 | - | - |
| 2014/03 | - | - | 474億 +37.1% | - | - | |
| 2015/03 | - | - | 526億 +10.9% | - | - | |
| 2016/03 | - | - | 649億 +23.4% | - | 51.4億 | |
| 2017/03 | - | - | 756億 +16.5% | - | 68.9億 +34.1% | |
| 2018/03 | - | - | 810億 +7.2% | - | 73.4億 +6.6% | |
| 2019/03 | - | - | 846億 +4.5% | - | 84.4億 +14.9% | |
| 2020/03 | - | 121億 | 915億 +8.1% | - | 121億 +43.9% | |
| 2021/03 | - | 109億 -10.2% | 879億 -4% | - | - | |
| 2022/03 | - | 106億 -2.5% | 879億 ±-0% | - | - | |
| 2023/03 | - | 110億 +3.3% | 921億 +4.9% | - | - | |
| 2024/03 | 29.5億 | 114億 +3.8% | 919億 -0.2% | - | 89.3億 | |
| 2025/03 | 662億 +999.99% | - | 948億 +3.2% | - | 85.7億 -4.1% | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| 減損損失 | 2013/03 | - | - | 67百万 | - | - |
| 2014/03 | - | - | 136百万 +103% | - | - | |
| 2015/03 | - | - | 257百万 +89% | - | - | |
| 2016/03 | - | - | 497百万 +93.4% | - | - | |
| 2017/03 | - | - | 152百万 -69.4% | - | - | |
| 2018/03 | - | - | 661百万 +334.9% | - | 158百万 | |
| 2019/03 | - | - | 340百万 -48.6% | - | - | |
| 2020/03 | - | - | 295百万 -13.2% | - | - | |
| 2021/03 | - | 308百万 | 451百万 +52.9% | - | - | |
| 2022/03 | - | - | 374百万 -17.1% | - | - | |
| 2023/03 | - | 100百万 | 360百万 -3.7% | - | - | |
| 2024/03 | - | - | 325百万 -9.7% | - | - | |
| 2025/03 | - | - | 112百万 -65.5% | - | - | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| のれん | 2013/03 | - | - | 79.2億 | - | - |
| 2014/03 | - | - | 134億 +69.4% | - | - | |
| 2015/03 | - | - | 168億 +25.2% | - | - | |
| 2016/03 | - | - | 151億 -10.1% | - | 23.6億 | |
| 2017/03 | - | - | 264億 +75% | - | 21.5億 -8.9% | |
| 2018/03 | - | - | 253億 -4.1% | - | 18億 -16.2% | |
| 2019/03 | - | - | 276億 +8.7% | - | 18.1億 +0.5% | |
| 2020/03 | - | 24.4億 | 335億 +21.7% | - | 24.4億 +34.9% | |
| 2021/03 | - | 21.6億 -11.6% | 319億 -4.9% | - | - | |
| 2022/03 | - | 18.7億 -13% | 305億 -4.5% | - | - | |
| 2023/03 | - | 14.9億 -20.4% | 313億 +2.8% | - | - | |
| 2024/03 | 4.78億 | 19億 +27.5% | 302億 -3.5% | - | 14.2億 | |
| 2025/03 | 85.9億 +999.99% | - | 296億 -1.9% | - | 11.6億 -18.9% | |
| 科目 | 年度 | 製薬事業 | 医療関連事業 | 保険薬局事業 | 薬局事業 | BPO事業 |
| のれん償却額 | 2013/03 | - | - | 5.73億 | - | - |
| 2014/03 | - | - | 9.58億 +67.2% | - | - | |
| 2015/03 | - | - | 12.8億 +33.5% | - | - | |
| 2016/03 | - | - | 13.6億 +6.3% | - | 209百万 | |
| 2017/03 | - | - | 17.4億 +27.7% | - | 209百万 ±0% | |
| 2018/03 | - | - | 21.3億 +22.7% | - | 209百万 ±0% | |
| 2019/03 | - | - | 22.2億 +4% | - | 181百万 -13.4% | |
| 2020/03 | - | 240百万 | 27.3億 +23.1% | - | 240百万 +32.6% | |
| 2021/03 | - | 281百万 +17.1% | 28.1億 +2.9% | - | - | |
| 2022/03 | - | 281百万 ±0% | 28.9億 +2.8% | - | - | |
| 2023/03 | - | 281百万 ±0% | 29.2億 +1.2% | - | - | |
| 2024/03 | 87百万 | 356百万 +26.7% | 30.4億 +3.9% | - | 269百万 | |
| 2025/03 | 998百万 +999.99% | - | 30.6億 +0.9% | - | 269百万 ±0% |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 医療関連事業 | ||||||
| 売上高 1Q2Q 3Q | 2020/03 | 28億 | - | - | - | - |
| 2021/03 | 34.6億 +23.5% | 33億 | 31.7億 | 31.9億 | 131億 | |
| 2022/03 | 31.7億 -8.2% | 33億 +0.1% | 31.8億 +0.4% | 34.4億 +7.9% | 131億 -0.1% | |
| 2023/03 | 33.9億 +6.9% | 35.1億 +6.3% | 39.1億 +23% | 38.5億 +12% | 147億 +12% | |
| 2024/03 | 38.6億 +13.7% | 28.2億 -19.7% | 46億 +17.5% | 36.8億 -4.5% | 150億 +2% | |
| 営業利益 1Q2Q 3Q | 2020/03 | 4.31億 | - | - | - | - |
| 2021/03 | 6.11億 +41.8% | 3.24億 | 3.08億 | 2.33億 | 14.8億 | |
| 2022/03 | 3.11億 -49.1% | 3.52億 +8.6% | 2.67億 -13.3% | 2.6億 +11.6% | 11.9億 -19.4% | |
| 2023/03 | 3.49億 +12.2% | 2.96億 -15.9% | 5.13億 +92.1% | 3.76億 +44.6% | 15.3億 +28.9% | |
| 2024/03 | 3.27億 -6.3% | 4.74億 +60.1% | 0.83億 -83.8% | 2.52億 -33% | 11.4億 -25.9% | |
| 営業利益率 | 2020/03 | 15.4% | - | - | - | - |
| 2021/03 | 17.7% +2.3% | 9.8% | 9.7% | 7.3% | 11.3% | |
| 2022/03 | 9.8% -7.9% | 10.7% +0.9% | 8.4% -1.3% | 7.6% +0.3% | 9.1% -2.2% | |
| 2023/03 | 10.3% +0.5% | 8.4% -2.3% | 13.1% +4.7% | 9.8% +2.2% | 10.5% +1.4% | |
| 2024/03 | 8.5% -1.8% | 16.8% +8.4% | 1.8% -11.3% | 6.9% -2.9% | 7.6% -2.9% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 保険薬局事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 222億 | 223億 | 236億 | 233億 | 913億 |
| 2015/03 | 247億 +11.4% | 254億 +14.1% | 268億 +13.5% | 263億 +13.2% | 1032億 +13.1% | |
| 2016/03 | 266億 +8% | 275億 +8.3% | 303億 +13% | 308億 +17.1% | 1153億 +11.7% | |
| 2017/03 | 273億 +2.6% | 277億 +0.7% | 329億 +8.6% | 326億 +5.8% | 1206億 +4.6% | |
| 2018/03 | 328億 +20% | 333億 +20.1% | 345億 +4.7% | 345億 +5.8% | 1351億 +12% | |
| 2019/03 | 320億 -2.4% | 317億 -4.8% | 345億 +0.1% | 359億 +4% | 1341億 -0.7% | |
| 2020/03 | 375億 +17.1% | 381億 +20.2% | 392億 +13.5% | 384億 +7% | 1532億 +14.2% | |
| 2021/03 | 357億 -4.8% | 366億 -3.9% | 386億 -1.5% | 378億 -1.4% | 1487億 -2.9% | |
| 2022/03 | 372億 +4.1% | 382億 +4.2% | 395億 +2.6% | 382億 +1% | 1531億 +2.9% | |
| 2023/03 | 372億 -0.1% | 384億 +0.6% | 397億 +0.5% | 401億 +4.9% | 1554億 +1.5% | |
| 2024/03 | 395億 +6.4% | 414億 +7.9% | 423億 +6.4% | 418億 +4.4% | 1651億 +6.3% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 9.95億 | 5.09億 | 10.3億 | 5.06億 | 30.4億 |
| 2015/03 | 7.45億 -25.1% | 9.09億 +78.6% | 15.2億 +47.9% | 12.5億 +146.4% | 44.2億 +45.5% | |
| 2016/03 | 12.3億 +64.7% | 14.8億 +63.3% | 18.9億 +24.7% | 21.1億 +69% | 67.1億 +51.9% | |
| 2017/03 | 7.7億 -37.2% | 12.1億 -18.5% | 19.9億 +5% | 21.9億 +4% | 61.6億 -8.2% | |
| 2018/03 | 17.8億 +130.5% | 21.3億 +75.9% | 26.2億 +31.8% | 21.3億 -3% | 86.5億 +40.4% | |
| 2019/03 | 12.9億 -27.5% | 15.6億 -26.6% | 17.6億 -32.8% | 17.4億 -18.3% | 63.5億 -26.6% | |
| 2020/03 | 15億 +16.2% | 18.1億 +16.1% | 17.1億 -3% | 22.4億 +28.8% | 72.6億 +14.3% | |
| 2021/03 | 10.5億 -30.1% | 21.3億 +17.4% | 29.3億 +71.8% | 35億 +56.2% | 96.1億 +32.4% | |
| 2022/03 | 22.9億 +118.8% | 29億 +35.9% | 32.3億 +10.2% | 34.5億 -1.3% | 119億 +23.5% | |
| 2023/03 | 21.4億 -6.4% | 29.2億 +0.8% | 32.2億 -0.4% | 32.2億 -6.6% | 115億 -3.1% | |
| 2024/03 | 24.2億 +13.2% | 22.9億 -21.4% | 28.8億 -10.6% | 31.4億 -2.7% | 107億 -6.7% | |
| 営業利益率 | 2014/03 | 4.5% | 2.3% | 4.3% | 2.2% | 3.3% |
| 2015/03 | 3% -1.5% | 3.6% +1.3% | 5.7% +1.4% | 4.7% +2.5% | 4.3% +1% | |
| 2016/03 | 4.6% +1.6% | 5.4% +1.8% | 6.3% +0.6% | 6.8% +2.1% | 5.8% +1.5% | |
| 2017/03 | 2.8% -1.8% | 4.4% -1% | 6% -0.3% | 6.7% -0.1% | 5.1% -0.7% | |
| 2018/03 | 5.4% +2.6% | 6.4% +2% | 7.6% +1.6% | 6.2% -0.5% | 6.4% +1.3% | |
| 2019/03 | 4% -1.4% | 4.9% -1.5% | 5.1% -2.5% | 4.8% -1.4% | 4.7% -1.7% | |
| 2020/03 | 4% ±0% | 4.8% -0.1% | 4.4% -0.7% | 5.8% +1% | 4.7% ±0% | |
| 2021/03 | 2.9% -1.1% | 5.8% +1% | 7.6% +3.2% | 9.2% +3.4% | 6.5% +1.8% | |
| 2022/03 | 6.1% +3.2% | 7.6% +1.8% | 8.2% +0.6% | 9% -0.2% | 7.7% +1.2% | |
| 2023/03 | 5.8% -0.3% | 7.6% ±0% | 8.1% -0.1% | 8% -1% | 7.4% -0.3% | |
| 2024/03 | 6.1% +0.3% | 5.5% -2.1% | 6.8% -1.3% | 7.5% -0.5% | 6.5% -0.9% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| BPO事業 | ||||||
| 売上高 1Q2Q 3Q | 2015/03 | 26億 | 29.1億 | 27.8億 | - | - |
| 2016/03 | 22.7億 -12.6% | 23.3億 -19.9% | 23.9億 -13.9% | 26.5億 | 96.5億 | |
| 2017/03 | 27.7億 +21.7% | 27.3億 +16.8% | 27.2億 +13.6% | 27億 +1.7% | 109億 +13% | |
| 2018/03 | 26.8億 -3.3% | 26億 -4.8% | 26.1億 -4% | 25.5億 -5.3% | 104億 -4.3% | |
| 2019/03 | 27.5億 +2.7% | 25.4億 -2.2% | 26.9億 +3.2% | 26.8億 +5.1% | 107億 +2.2% | |
| 2020/03 | 28億 +1.9% | 28.1億 +10.7% | 32.7億 +21.4% | 33.5億 +24.8% | 122億 +14.7% | |
| 2021/03 | - | - | 31.7億 -3% | - | - | |
| 営業利益 1Q2Q 3Q | 2015/03 | 0.76億 | 3.36億 | 1.95億 | - | - |
| 2016/03 | 2.9億 +281.6% | 2.34億 -30.4% | 2.55億 +30.8% | 2.21億 | 10億 | |
| 2017/03 | 4.59億 +58.3% | 3.32億 +41.9% | 3.63億 +42.4% | 3.44億 +55.7% | 15億 +49.8% | |
| 2018/03 | 4.5億 -2% | 3.05億 -8.1% | 3.42億 -5.8% | 2.44億 -29.1% | 13.4億 -10.5% | |
| 2019/03 | 4.18億 -7.1% | 2.39億 -21.6% | 2.76億 -19.3% | 4.33億 +77.5% | 13.7億 +1.9% | |
| 2020/03 | 4.31億 +3.1% | 2.96億 +23.8% | 3.11億 +12.7% | 3.06億 -29.3% | 13.4億 -1.6% | |
| 2021/03 | - | - | 2.77億 -10.9% | - | - | |
| 営業利益率 | 2015/03 | 2.9% | 11.5% | 7% | - | - |
| 2016/03 | 12.8% +9.9% | 10% -1.5% | 10.7% +3.7% | 8.3% | 10.4% | |
| 2017/03 | 16.6% +3.8% | 12.2% +2.2% | 13.4% +2.7% | 12.8% +4.5% | 13.7% +3.3% | |
| 2018/03 | 16.8% +0.2% | 11.8% -0.4% | 13.1% -0.3% | 9.6% -3.2% | 12.9% -0.8% | |
| 2019/03 | 15.2% -1.6% | 9.4% -2.4% | 10.3% -2.8% | 16.1% +6.5% | 12.8% -0.1% | |
| 2020/03 | 15.4% +0.2% | 10.5% +1.1% | 9.5% -0.8% | 9.1% -7% | 11% -1.8% | |
| 2021/03 | - | - | 8.7% -0.8% | - | - | |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
